Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
2.920
-0.190 (-6.11%)
Mar 13, 2026, 4:00 PM EDT - Market closed

Cryo-Cell International Income Statement

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
31.5731.9931.3430.3428.88
Revenue Growth (YoY)
-1.31%2.05%3.32%5.03%-7.26%
Cost of Revenue
7.387.958.398.798.99
Gross Profit
24.1924.0422.9521.5419.9
Selling, General & Admin
18.2218.5217.1715.5814.61
Depreciation & Amortization Expenses
0.750.481.121.120.83
Research & Development
0.381.241.170.380.05
Other Operating Expenses
4.360.3115.790.440.38
Total Operating Expenses
23.7120.5635.2617.5215.88
Operating Income
0.483.48-12.34.024.02
Interest Expense
-2.07-1.86-1.24-1.52-1.38
Other Non-Operating Income (Expense)
-0.751.190.180.82-0.03
Total Non-Operating Income (Expense)
-2.82-0.68-1.06-0.71-1.41
Pretax Income
-2.342.8-13.363.322.61
Provision for Income Taxes
0.092.4-3.840.550.53
Net Income
-2.430.4-9.522.772.08
Net Income to Common
-2.430.4-9.522.772.08
Net Income Growth
---33.02%-42.52%
Shares Outstanding (Basic)
88888
Shares Outstanding (Diluted)
88888
Shares Change (YoY)
-1.75%-1.54%-1.69%1.46%2.72%
EPS (Basic)
-0.300.05-1.140.330.26
EPS (Diluted)
-0.300.05-1.140.330.25
EPS Growth
---32.00%-44.44%
Free Cash Flow
5.253.612.08-3.66.09
Free Cash Flow Growth
45.49%73.36%---27.19%
Free Cash Flow Per Share
0.650.440.25-0.420.73
Dividends Per Share
0.4000.250---
Dividend Growth
60.00%----
Gross Margin
76.63%75.15%73.23%71.02%68.88%
Operating Margin
1.53%10.88%-39.26%13.27%13.91%
Profit Margin
-7.70%1.26%-30.38%9.14%7.21%
FCF Margin
16.63%11.28%6.64%-11.85%21.09%
EBITDA
1.474.17-10.95.525.06
EBITDA Margin
4.65%13.05%-34.79%18.21%17.51%
EBIT
0.483.48-12.34.024.02
EBIT Margin
1.53%10.88%-39.26%13.27%13.91%
Effective Tax Rate
-3.95%85.66%28.75%16.50%20.21%
Updated Nov 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q